Beurs gesloten -
Nasdaq
22:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
11,29
USD
|
+4,15%
|
|
+34,89%
|
+0,27%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
62,47
|
231,6
|
182
|
113,8
|
202,9
|
212
|
-
|
-
|
Bedrijfswaarde
1 |
62,47
|
231,6
|
182
|
113,8
|
202,9
|
212
|
212
|
212
|
K/w-verhouding
|
-7,73
x
|
-17
x
|
-5,43
x
|
-4,17
x
|
-6,74
x
|
-5,14
x
|
-5,77
x
|
-6,05
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
-
|
21.206
x
|
1.006
x
|
304
x
|
1.309
x
|
5.678
x
|
3.686
x
|
3.563
x
|
Bedrijfswaarde/omzet
|
-
|
21.206
x
|
1.006
x
|
304
x
|
1.309
x
|
5.678
x
|
3.686
x
|
3.563
x
|
Bedrijfswaarde/EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfswaarde/FCF
|
-
|
-
|
-4.122.349
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
10.771
|
13.448
|
17.843
|
17.946
|
18.022
|
18.775
|
-
|
-
|
Referentieprijs
2 |
5,800
|
17,22
|
10,20
|
6,340
|
11,26
|
11,29
|
11,29
|
11,29
|
Datum van publicatie
|
11/03/20
|
4/03/21
|
3/03/22
|
2/03/23
|
28/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
-
|
0,0109
|
0,181
|
0,374
|
0,155
|
0,0373
|
0,0575
|
0,0595
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-7,756
|
-12,23
|
-29,15
|
-25,95
|
-29,74
|
-41,27
|
-39,34
|
-40,24
|
Operationele Marge
|
-
|
-111.975,09%
|
-16.106,63%
|
-6.938,77%
|
-19.187,74%
|
-110.549,16%
|
-68.418,26%
|
-67.631,09%
|
Resultaat voor belastingen (EBT)
1 |
-7,678
|
-12,1
|
-30,34
|
-27,3
|
-30,01
|
-41,21
|
-39,4
|
-40,3
|
Nettowinst (verlies)
1 |
-7,678
|
-12,1
|
-30,34
|
-27,3
|
-30,01
|
-41,21
|
-39,4
|
-40,3
|
Nettomarge
|
-
|
-110.798,17%
|
-16.762,43%
|
-7.299,2%
|
-19.360%
|
-110.404,5%
|
-68.519,13%
|
-67.728,57%
|
WPA
2 |
-0,7500
|
-1,010
|
-1,880
|
-1,520
|
-1,670
|
-2,197
|
-1,955
|
-1,865
|
Free Cash Flow
|
-
|
-
|
-44,15
|
-
|
-
|
-
|
-
|
-
|
FCF-marge
|
-
|
-
|
-24.392,27%
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
11/03/20
|
4/03/21
|
3/03/22
|
2/03/23
|
28/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Omzet
1 |
0,014
|
0,163
|
0,163
|
0,016
|
0,098
|
0,097
|
-
|
0,046
|
0,043
|
0,028
|
0,028
|
0,028
|
0,028
|
0,028
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-9,021
|
-9,03
|
-6,478
|
-6,388
|
-7,443
|
-5,642
|
-
|
-6,411
|
-8,528
|
-8,379
|
-9,34
|
-10,41
|
-11,62
|
-12,96
|
Operationele Marge
|
-64.435,71%
|
-5.539,88%
|
-3.974,23%
|
-39.925%
|
-7.594,9%
|
-5.816,49%
|
-
|
-13.936,96%
|
-19.832,56%
|
-29.925%
|
-33.357,14%
|
-37.192,86%
|
-41.489,29%
|
-46.300%
|
Resultaat voor belastingen (EBT)
1 |
-9,458
|
-9,671
|
-6,903
|
-6,838
|
-7,725
|
-5,833
|
-
|
-6,501
|
-8,563
|
-8,408
|
-9,369
|
-10,44
|
-11,65
|
-12,99
|
Nettowinst (verlies)
1 |
-9,458
|
-9,671
|
-6,903
|
-6,838
|
-7,725
|
-5,833
|
-6,536
|
-6,501
|
-8,563
|
-8,408
|
-9,644
|
-10,88
|
-12,24
|
-13,68
|
Nettomarge
|
-67.557,14%
|
-5.933,13%
|
-4.234,97%
|
-42.737,5%
|
-7.882,65%
|
-6.013,4%
|
-
|
-14.132,61%
|
-19.913,95%
|
-30.028,57%
|
-34.444,64%
|
-38.862,5%
|
-43.725%
|
-48.862,5%
|
WPA
2 |
-0,5500
|
-0,5500
|
-0,3900
|
-0,3800
|
-0,4300
|
-0,3200
|
-0,3600
|
-0,3600
|
-0,4800
|
-0,4700
|
-0,5350
|
-0,5950
|
-0,6600
|
-0,6550
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
3/11/21
|
3/03/22
|
5/05/22
|
3/08/22
|
2/11/22
|
2/03/23
|
3/05/23
|
7/08/23
|
1/11/23
|
28/03/24
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-44,2
|
-
|
-
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
15
|
-
|
-
|
-
|
-
|
-
|
Capex/omzet
|
-
|
-
|
8.287,29%
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
11/03/20
|
4/03/21
|
3/03/22
|
2/03/23
|
28/03/24
|
-
|
-
|
-
|
Laatste slotkoers
11,29
USD Gemiddelde koersdoel
19,67
USD Spread / Gemiddelde doel +74,20% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +0,27% | 212 mln. | | -2,31% | 103 mld. | | +0,56% | 95,28 mld. | | +1,69% | 22,15 mld. | | -17,37% | 21,02 mld. | | -9,30% | 18,15 mld. | | -41,01% | 16,74 mld. | | -14,85% | 16,05 mld. | | +3,21% | 13,68 mld. | | +33,54% | 12,17 mld. |
Biotherapeutische geneesmiddelen
|